Powder free. Non-sterile. Textured fingertips. Tested for use with 15 chemotherapy drugs. Berryblue Nitrile formulation. Low dermatitis potential. Quality alternative to latex gloves. Use for first aid, health care, chemotherapy, baby care, diabetes and more. The ASTM has established minimum quality standards for the manufacture of safe and effective infection control devices. This product exceeds ASTM minimum standards. This exam glove is intended to protect the wearer and/or the subject from contamination. Meets ASTM D6978 for resistance to permeation by chemotherapy drugs. Meets ASTM D6319 standard specification for nitrile exam gloves. Tested for viral penetration per ASTM F1671. Chemotherapy Drug Permeation (Average breakthrough detection time in minutes): Carmustine (BCNU) 3.3 mg/mL (3,300 ppm) - not recommended for use; Cisplatin 1.0 mg/mL (1,000 ppm) >240; Cyclophosphamide (Cytoxan) 20.0 mg/mL (20,000 ppm) >240; Cytarabine 100 mg/mL (100,000 ppm) >240; Dacarbazine (DTIC) 10.0 mg/mL (10,000 ppm) >240; Doxorubicin Hydrochloride 2.0 mg/mL (2,000 ppm) >240; Etoposide (Toposar) 20.0 mg/mL (20,000 ppm) >240; Fluorouracil 50.0 mg/mL (50,000 ppm) >240; Ifosfamide 50.0 mg/mL (50,000 ppm) >240; Methotrexate 25 mg/mL (25,000 ppm) >240; Mitomycin C 0.5 mg/mL (500 ppm) >240; Mitoxantrone 2.0 mg/mL (2,000 ppm) >240; Paclitaxel (Taxol) 6.0 mg/mL (6,000 ppm) >240; Thiotepa 10.0 mg/mL (10,000 ppm) not recommended for use; Vincristine Sulfate 1.0 mg/mL (1,000 ppm) >240.
